Stage IIIC Ovarian Cancer AJCC v8

Oncology

Prevalence

24.0 / 100K

Incidence

10.6 / 100K/yr

0 drugs in development·0 companies·3 clinical trials

Frequently asked questions

How many clinical trials target Stage IIIC Ovarian Cancer AJCC v8?

There are 3 clinical trials targeting Stage IIIC Ovarian Cancer AJCC v8 tracked by BioSniper.

What is the prevalence of Stage IIIC Ovarian Cancer AJCC v8?

The estimated prevalence of Stage IIIC Ovarian Cancer AJCC v8 is approximately 24.0 per 100,000 population.

Deep-dive into Stage IIIC Ovarian Cancer AJCC v8

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Stage IIIC Ovarian Cancer AJCC v8 — Drugs in Development & Clinical Trials | BioSniper